ATAI Life Sciences NV (ATAI)
1.99
+0.21
(+11.80%)
USD |
NASDAQ |
Mar 28, 11:50
ATAI Life Sciences Revenue (TTM): 0.334M for Sept. 30, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
September 30, 2023 | 0.334M |
June 30, 2023 | 0.271M |
Date | Value |
---|---|
March 31, 2023 | 0.269M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
0.269M
Minimum
Mar 2023
0.334M
Maximum
Sep 2023
0.2913M
Average
0.271M
Median
Jun 2023
Revenue (TTM) Benchmarks
Affimed NV | 19.91M |
InflaRx NV | -- |
MorphoSys AG | 257.99M |
BioNTech SE | 4.122B |
Immatics NV | 58.49M |